Title : Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients.

Pub. Date : 2015 Aug 28

PMID : 26057634






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Immunohistochemistry analysis of galunisertib and sorafenib-exposed samples showed a significant decrease of the proliferative marker Ki67 and increase of the apoptotic marker caspase-3. Sorafenib caspase 3 Homo sapiens